E
BioAge Labs, Inc. BIOA
$4.51 -$0.10-2.17% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -79.03M -71.05M -71.11M -70.94M -62.16M
Total Depreciation and Amortization 180.00K 171.00K 167.00K 161.00K 171.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 10.95M 9.32M 8.24M 13.77M 17.08M
Change in Net Operating Assets 10.49M 8.34M 11.18M 2.12M -2.82M
Cash from Operations -57.40M -53.21M -51.52M -54.89M -47.72M
Capital Expenditure -916.00K -792.00K -366.00K -340.00K -134.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -93.04M -77.56M -- 0.00 0.00
Cash from Investing -93.96M -78.35M -366.00K -340.00K -134.00K
Total Debt Issued -- -- -- 0.00 0.00
Total Debt Repaid -6.00M -6.00M -6.00M -5.50M -4.00M
Issuance of Common Stock 221.83M 222.25M 222.25M 194.61M 429.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock 542.00K 542.00K 170.54M 170.54M 170.00M
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -3.79M -5.09M -5.60M -4.37M -1.87M
Cash from Financing 212.59M 211.70M 381.20M 355.29M 164.56M
Foreign Exchange rate Adjustments 21.00K 50.00K 81.00K -121.00K -28.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 61.25M 80.18M 329.39M 299.94M 116.68M